Background
A dummy run was conducted to ensure the quality of intensity-modulated radiotherapy (IMRT) for elderly patients with newly diagnosed glioblastoma in a study by the Japan Clinical Oncology Group (JCOG1910).
Methods
41 institutions participated in this study, each required to report their treatment plans for a benchmark case. They outlined the necessary volumes for tumor treatment and created plans using two different radiation doses. The outlining quality and dose criteria were evaluated for each institution.
Results
Six institutions needed to revise their plans due to poor tumor outlining and incorrect treatment volume adjustments. Most institutions met the dose-volume criteria, with only one failing to do so.
Conclusions
Many institutions showed deviations in their outlining, which requires corrective feedback. Continuous communication and information sharing is critical for the success of the upcoming JCOG1910 study.
Opportunities Based on Trial Data
To improve treatment quality for patients:
- Define Measurable Outcomes: Set clear goals for outlining and treatment plans to enhance patient care in clinics.
- Select AI Tools: Choose AI solutions tailored to specific clinical needs to support treatment planning.
- Implement Step by Step: Start with a pilot project using AI, track results, and assess the real-world impact of the findings from the study.
Contact Us for AI Solutions in Medical Management
For further information on AI solutions for enhancing medical management, reach out to us:
